Table 2.
The treatment of retinal capillary hemangioblastoma in 23 eyes
| Variable | Sporadic (n = 6) | VHL disease- related (n = 17) |
|---|---|---|
| Observation without treatment | 2 (33) | 5 (29) |
| Intravitreal anti-VEGF injection | 4 (67) | 6 (35) |
| Response | 3 (75) | 2 (33) |
| Nonresponse | 1 (25) | 4 (67) |
| ≥2 Times | 4 (100) | 4 (67) |
| Requiring other treatments | 3 (75) | 6 (100) |
| Laser photocoagulation | 2 (33) | 6 (35) |
| Focal laser | 2 (100) | 2 (33) |
| Barrier laser | 0 (0) | 3 (50) |
| Focal and barrier laser | 0 (0) | 1 (17) |
| Requiring other treatments | 2 (100) | 4 (67) |
| Photodynamic therapy (requiring other treatments) | 1 (17) | 2 (12) |
| Cryotherapy | 2 (33) | 3 (18) |
| Vitrectomy | 1 (17) | 5 (29) |
| ≥2 Times | 1 (100) | 3 (60) |
| Encircling buckles | 0 (0) | 1 (17) |
Values are presented as number (%).
VHL = von Hippel-Lindau; VEGF = vascular endothelial growth factor.